Topics
BECTON DICKINSON & CO. $202 is a buy. The medical device maker (New York symbol BDX; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 285.2 million; Market cap: $57.6 billion; Price-to-sales ratio: 2.5; Dividend yield: 2.1%; TSINetwork Rating: Above Average; www.bd.com) plans to expand glass syringe production at its Columbus, Nebraska, facility. That positions the company to benefit from rising demand for GLP-1 weight-loss drugs and other injectable medicines. Becton expects to complete the $110 million project by mid-2026.
The share price for each of these Japanese automakers has held up over the past year. That’s despite new U.S. tariffs and slowing consumer demand for electric vehicles. Toyota and Honda are managing costs effectively while continuing to invest in new technologies; their successful balancing act should lead to long-term earnings growth. TOYOTA MOTOR CO. ADRs $219 is a buy. The company (New York symbol TM; Conservative Growth Portfolio, Manufacturing & Industry sector; ADRs outstanding: 1.3 billion; Market cap: $284.7 billion; Price-to-sales ratio: 0.9; Dividend yield: 2.8%; TSINetwork Rating: Above Average; www.toyota.com) is Japan’s largest automaker by production volume.
IDEXX LABORATORIES INC. $688 is a hold. The company (Nasdaq symbol IDXX; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 80.4 million; Market cap: $55.3 billion; Price-to-sales ratio: 13.6; No dividends paid; TSINetwork Rating: Average; www.idexx.com) makes equipment that veterinarians use to detect disease in animals. Back in 2024, Idexx launched its inVue Dx analyzer, which delivers blood test results in under 10 minutes. The device is in strong demand, and management raised its 2025 delivery target to 5,500 units from 4,500.
These two makers of testing equipment are doing a good job tapping into key trends. Agilent is seeing strong demand from developers of new GLP-1 weight loss drugs, while demand for new chips to run artificial intelligence programs is driving demand for Keysight’s chip-testing gear. We still see both as aggressive buys. AGILENT TECHNOLOGIES INC. $134 is a buy. The company (New York symbol A; Aggressive Growth Portfolio, Manufacturing sector; Shares outstanding: 283.5 million; Market cap: $38.0 billion; Price-to-sales ratio: 5.6; Dividend yield: 0.8%; TSINetwork Rating: Average; www.agilent.com) makes specialized testing equipment for medical research laboratories and industrial clients.
YUM! BRANDS INC. $154 is a buy. The fast-food giant (New York symbol YUM; Aggressive Growth Portfolio, Consumer Sector; Shares outstanding: 277.5 million; Market cap: $42.7 billion; Price-to-sales ratio: 5.4; Dividend yield: 1.8%; TSINetwork Rating: Average; www.yum.com) operates 62,000 restaurants in over 155 countries. Its main banners are KFC (fried chicken), Pizza Hut, and Taco Bell (Mexican food). The company is now conducting a strategic review of its Pizza Hut chain. The U.S. market, which accounts for roughly 42% of its sales, has been under pressure as cost-conscious consumers reduce spending on in-store dining and takeout.
FEDEX CORP. $315 is a buy. The company (New York symbol FDX; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 235.1 million; Market cap: $74.1 billion; Price-to-sales ratio: 0.8; Dividend yield: 1.8%; TSINetwork Rating: Average; www.fedex.com) delivers packages and documents in the U.S. and 220 other countries. FedEx plans to spin off its freight division into a separate publicly traded company, FedEx Freight Holding Co. Inc. (New York symbol FDXF). The business is a leading provider of less-than-truckload (LTL) services, which consolidate shipments from multiple customers into a single vehicle.
The shares of three foodmakers have fallen sharply in recent months, reflecting several pressures, including higher costs from tariffs, a shift toward healthier diets, and the growing use of weight-loss drugs such as Ozempic. In response, all three companies are cutting costs and improving product quality—steps that should help revive sales and boost profits. Stronger earnings should also support their dividends. We view all three as high-quality buys for patient investors.
TEXAS INSTRUMENTS INC. $216 is a buy. The company (Nasdaq symbol TXN; Aggressive Growth Portfolio, Manufacturing sector; Shares outstanding: 908.6 million; Market cap: $196.3 billion; Price-to-sales ratio: 10.2: Dividend yield: 2.6%; TSINetwork Rating: Average; www.ti.com) specializes in analog chips, which convert inputs like touch and sound into electronic signals that computers can understand.
For 2026, we have selected three Stocks of the Year—one from each of our portfolios (Conservative, Aggressive, and Income). These companies offer an attractive mix of growth and value, which positions them to deliver above-average returns in 2026 and over the long term.
WALMART INC. $117 is your #1 Conservative Buy for 2026. The company (Nasdaq symbol WMT; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 8.0 billion; Market cap: $936.0 billion; Price-to-sales ratio: 1.3; Dividend yield: 0.8%; TSINetwork Rating: Above Average; www.walmart.com) is the world’s largest retailer with 10,822 outlets in 19 countries. Those stores serve a total of 270 million customers each week.

You Can See Our Cyclical-Growth Dividend Payer Portfolio for February 2026 Here